Medpace Holdings (MEDP) Other Non Operating Income (2015 - 2026)
Medpace Holdings' (MEDP) quarterly Other Non Operating Income came in at -$147000.0 in Q2 2026, up 94.89% on a YoY basis from -$75428.3 in Q2 2025, and down 115.14% quarter-over-quarter from $971000.0 in Q1 2026.
Analysis
Medpace Holdings (MEDP) Other Non Operating Income (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has reported Other Non Operating Income for 12 consecutive years, with -$147000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Non Operating Income rose 94.89% year-over-year to -$147000.0; the trailing twelve-month figure through Jun 2026 stood at $177000.0 (up 103.47% YoY), and the FY2025 full-year result was -$5.3 million, down 231.61% from the prior year.
- Other Non Operating Income fell to -$147000.0 in Q2 2026 per MEDP's latest filing, from $971000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $5.6 million in Q3 2022 and bottomed at -$2.9 million in Q2 2025.
- Historically, Other Non Operating Income has averaged $330833.3 across 5 years, with a median of -$140000.0 in 2024.
- The sharpest annual moves came in 2022 and 2025: Other Non Operating Income jumped 772.08% in 2022, then sank 2061.65% in 2025.
- Over 5 years, Other Non Operating Income stood at -$2.0 million in 2022, then soared by 178.76% to $1.5 million in 2023, then sank by 59.75% to $621000.0 in 2024, then plunged by 125.44% to -$158000.0 in 2025, then gained by 6.96% to -$147000.0 in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered -$147000.0, $971000.0, and -$158000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -147,000.00 |
| Mar 31, 2026 | 971,000.00 |
| Dec 31, 2025 | -158,000.00 |
| Sep 30, 2025 | -489,000.00 |
| Jun 30, 2025 | -2.88 Mn |
| Mar 31, 2025 | -1.82 Mn |
| Dec 31, 2024 | 621,000.00 |
| Sep 30, 2024 | -1.03 Mn |
| Jun 30, 2024 | -133,000.00 |
| Mar 31, 2024 | 4.59 Mn |
| Dec 31, 2023 | 1.54 Mn |
| Sep 30, 2023 | -1.60 Mn |
| Jun 30, 2023 | -1.28 Mn |
| Mar 31, 2023 | 687,000.00 |
| Dec 31, 2022 | -1.96 Mn |
| Sep 30, 2022 | 5.65 Mn |
| Jun 30, 2022 | 2.31 Mn |
| Mar 31, 2022 | 1.07 Mn |
| Dec 31, 2021 | 1.09 Mn |
| Sep 30, 2021 | 1.06 Mn |